Pharma Group Takes Swipe At EU Antitrust Probe

Law360, New York (May 14, 2009, 12:00 AM EDT) -- An official from the European Federation of Pharmaceutical Industries and Associations has reportedly taken aim at a preliminary inquiry from the European Commission's Directorate General for Competition into whether Europe's pharmaceutical companies are blocking generic competition, arguing that the inquiry's findings could weaken patent enforcement rules and hinder innovation.

Thomas Cueni, head of Swiss pharmaceutical research association Interpharma and leader of the EFPIA's task force responding to the November inquiry, said in a speech during the federation’s annual meeting Thursday that the inquiry misplaced blame for...
To view the full article, register now.